Serological evidence of exposure to Besnoitia besnoiti, Neospora caninum, and Toxoplasma gondii in dairy cows from Costa Rica
Tropical Animal Health and Production · 2026
DOI: 10.1007/s11250-026-05258-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Animal Health and Production, 2026. Verfasst von Daisy Elena Fallas-Elizondo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Maestría en Enfermedades Tropicales, Posgrado Regional en Ciencias Veterinarias Tropicales, Universidad Nacional (UNA), Heredia, Costa Rica. Hauptthemen laut MEDLINE: Coccidiosis, Toxoplasmosis, Animal, Cattle Diseases, Sarcocystidae. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Apicomplexan parasites affecting cattle compromise health and welfare, and some have zoonotic potential. This descriptive cross-sectional study assessed the serological evidence of exposure to Besnoitia besnoiti, Neospora caninum, and Toxoplasma gondii and described co-seropositivity patterns in dairy cows from the Huetar Norte Region of Costa Rica. Blood samples were collected from 600 cows on 40 specialized dairy or dual-purpose farms and tested using indirect immunoassays (IDVET, Montpellier, France). All sera were analyzed for B. besnoiti, and a structured subset of 327 sera, selected according to B. besnoiti serostatus, was evaluated for antibodies against N. caninum and T. gondii to describe co-seropositivity patterns. Seropositivity to B. besnoiti was 27.3% (164/600) in cows and 85.0% (34/40) in farms. In the subset, the proportion of seropositive animals was 29.4% for T. gondii (96/327) and 16.2% for N. caninum (53/327). At the farm level, based on the structured subset, 70.0% (28/40) of farms had at least one seropositive animal for T. gondii and 67.5% (27/40) for N. caninum. Co-seropositivity within the subset occurred for T. gondii/B. besnoiti in 41 cows (12.5%), N. caninum/B. besnoiti in 17 (5.2%), and T. gondii/N. caninum in 13 (3.9%); seven cows (2.1%) were seropositive to all three agents. These findings indicate frequent exposure to these apicomplexans in Huetar Norte herds, supporting strengthened biosecurity and preventive measures on farms, particularly for toxoplasmosis from a One Health perspective. Because T. gondii and N. caninum were assessed in a structured subset, these results should be interpreted as subset-level proportions and co-seropositivity patterns rather than population-level prevalence estimates for the full 600-cow sample.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Maestría en Enfermedades Tropicales, Posgrado Regional en Ciencias Veterinarias Tropicales, Universidad Nacional (UNA), Heredia, Costa Rica.
- Sede Regional Atenas, Universidad Técnica Nacional, Alajuela, Costa Rica.
- Programa de Investigación en Medicina Poblacional, Escuela de Medicina Veterinaria, UNA, Heredia, Costa Rica.
- Maestría en Enfermedades Tropicales, Posgrado Regional en Ciencias Veterinarias Tropicales, Universidad Nacional (UNA), Heredia, Costa Rica. gaby.dolz.wiedner@una.ac.cr.
- Programa de Investigación en Medicina Poblacional, Escuela de Medicina Veterinaria, UNA, Heredia, Costa Rica. gaby.dolz.wiedner@una.ac.cr.
Zitieren
APA
Fallas-Elizondo, D. E., Romero-Zúñiga, J. J., & Dolz, G. (2026). Serological evidence of exposure to Besnoitia besnoiti, Neospora caninum, and Toxoplasma gondii in dairy cows from Costa Rica. Tropical Animal Health and Production. https://doi.org/10.1007/s11250-026-05258-5
Vancouver
Fallas-Elizondo DE, Romero-Zúñiga JJ, Dolz G. Serological evidence of exposure to Besnoitia besnoiti, Neospora caninum, and Toxoplasma gondii in dairy cows from Costa Rica. Tropical Animal Health and Production. 2026. doi:10.1007/s11250-026-05258-5
BibTeX
@article{FallasElizondo2026,
author = {Fallas-Elizondo, Daisy Elena and Romero-Zúñiga, Juan José and Dolz, Gaby},
title = {Serological evidence of exposure to Besnoitia besnoiti, Neospora caninum, and Toxoplasma gondii in dairy cows from Costa Rica},
journal = {Tropical Animal Health and Production},
year = {2026},
doi = {10.1007/s11250-026-05258-5}
}
EUVIMED